FDA Drug Application (091634) for ALYACEN 1/35 by GLENMARK GENERICS

Back to FDA Applications sponsored by GLENMARK GENERICS

Application Number091634
Product Number001
FormTABLET;ORAL-28
Dosage0.035MG;1MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameALYACEN 1/35
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by GLENMARK GENERICS